|
Podcast: New Data and Emerging Management Strategies for Migraine Headache
STATEMENT OF NEED
Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually every aspect of their lives, including personal relationships, reproductive choices, and productivity i... |
|
|
New Data and Emerging Management Strategies for Migraine Headache
STATEMENT OF NEED
Migraine is a type of chronic headache disorder characterized by headaches of a stabbing, pulsatile quality that last between 4 and 72 hours each, often accompanied by symptoms of nausea and sensitivity to light and noise. An estimated 1.04 billion individuals have been diagnosed with migraine worldwide (Negro et al, 2019). Patients report that migraine impacts virtually every aspect of their lives, including personal relationships, reproductive choices, and productivity i... |
|
Applying ADAURA in Practice: Implications For Early Stage EGFRM NSCLC
This educational initiative is targeted to medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists and molecular pathologists who are involved in diagnosis of early stage NSCLC that is surgically resectable with curative intent. In addition to examining the latest ADAURA trial data and the potential utility of adjuvant osimertinib in stage IB-IIIA EGFRm NSCLC, the practice-changing implications of these results will also be explored from a variety of perspectives with thr... |
|
|
Exploring Best Practices for Diagnosis and Management of Hypereosinophilic Syndrome
Hypereosinophilic syndromes (HESs) are a broad group of disorders that can lead to serious complications, including cardiovascular disease, cerebrovascular disease, and death. Due to their rarity, however, HESs are challenging to diagnose and treat. In this in-depth review, presented by Princess Ogbogu, MD, and developed in collaboration with Michael Wechsler, MD, MMSc, the wide-ranging presentations of HES will be reviewed, along with pathophysiology, classification, and acute and chronic man... |
|
Facts on COVID-19 Vaccinations: Pfizer BioNTech
Pharmacists and other health professionals can play crucial roles in administering and advocating for vaccination, especially during the pandemic. Learners’ knowledge should stay up-to-date in order to serve the population and aid in efforts to gaining herd immunity with vaccinations. |
|
|
TEAM UP: Defining and Refining Optimal HIV Care During the COVID-19 Pandemic
In this webcast series, members of the DAP Health team review key data and discuss their real-world experiences providing care for persons living with HIV during the COVID-19 pandemic. DAP Health opened one of California’s first COVID-19 clinics and hotlines to offer screening, testing, and treatment.
Topics covered in this webcast series include:
COVID-19–Related Complications in Persons Living With HIV (PLWH);
COVID-19 Testing Strategies;
Home Care for PLWH Diagnosed With COVID-1... |
|
|
Pharmacy Technician Series: An Overview of Medications for Type 2 Diabetes
Objectives
Summarize the pathophysiology of Type 2 Diabetes
Classify the different medications used for Type 2 Diabetes
Apply knowledge of newer diabetes medications to a patient case
|
|
|
Sexual Harassment
Objectives
1. Define Sexual harassment, including its forms and types
2. Describe the two different types of sexual harassment
3. Explain how to handle sexual harassment experienced or witnessed in the workplace
4. Discuss the options available for reporting sexual harassment in the workplace
5. Describe state and federal protections against retaliation by employers (whistleblower protections) for reporting sexual harassment |
|
Preceptor Mini-Series 6: The Reason I Jump - An Interprofessional Mini-Series
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to educate both preceptors and students regarding their participation in experiential rotations in an Interprofessional setting. Each individual video episode is 8 - 14 minutes in length and builds upon the next. The series follows multiple health professional preceptors including nurses, pharmacists, physicians, speech-language-pathologists, occupational therapists, athlethic tr... |
|
|
Preceptor Mini-Series 5: Change of Heart - An Interprofessional Mini-Series
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to educate both preceptors and students regarding their participation in experiential rotations in an Interprofessional setting. Each individual video episode is 5-10 minutes in length and builds upon the next. The series follows multiple health professional preceptors including nurses, pharmacists, physicians, speech-language-pathologists, occupational therapists, and physical t... |
|
|
Preceptor Mini-Series 2: Adventures of Interprofessional Precepting
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to provide educational pearls to preceptors who train students or residents on experiential rotations in an Interprofessional setting.
Each video episode is 5-8 minutes in length and builds upon the next. The series follows three health professional preceptors including a nurse, pharmacist, and physician as they precept their students in an ambulatory care setting. Through a... |
|
|
Preceptor Mini-Series 1: Preceptor Pharm Tools
(See movie trailer below detailed description).
This is a 12 episode, knowledge-based, video series developed to provide educational pearls to preceptors who train pharmacy students or residents on experiential rotations. Each video episode is 5-8 minutes in length and builds upon the next. The series follows a young preceptor and two students through a 6 week clinical rotation at a hospital. The two students are polar opposites and present unique challenges to the preceptor. At moments ... |
|
|
Pharmacy Technician Series: Modified Medications: Its All in the Release
Often, pharmacy technicians are given no formal training in recognizing different dosage forms of the same drug. Not understanding the differences and importance of selecting the right medication can lead to medication errors and patient safety concerns down the road.
The goal is to make pharmacy technicians aware of the available dosage forms, and more comfortable choosing the right drug the first time. |
|
|
Veterinary Compounding Essentials
October 28 - 29, 2022
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge o... |
|
|
Veterinary Compounding Essentials
July 29 - 30, 2022
VETERINARY COMPOUNDING ESSENTIALS is an accredited 15 hour (1.5 CEUs) practice-based course that introduces pharmacists, technicians, and marketers to veterinary pharmacy compounding. The program provides fundamental techniques for effectively growing the veterinary compounding practice, including calculations, proper safety practices, hands-on compounding, and marketing.
Upon completion of this program, the participant will be able to:
• Demonstrate knowledge of a... |
|
|
Fundamental Compounding with Pharmacy Law
November 10 - 12, 2022
FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law.
This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other health care professionals are also welcome to attend.
CONTENT
This course provides didactic and hands... |
|
|
Fundamental Compounding with Pharmacy Law
September 8 - 10, 2022
FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law.
This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other health care professionals are also welcome to attend.
CONTENT
This course provides didactic and hands... |
|
|
Fundamental Compounding with Pharmacy Law
May 12 - 14, 2022
FUNDAMENTAL COMPOUNDING is an accredited 3-day course that combines a 20-hour (2.0 CEUs) practice-based course with a 1 hour (0.1 CEU) knowledge-based course in Fundamental Compounding Law.
This course is designed for pharmacists, technicians, and students who are new to compounding or who have had training in the past but want a refresher. Physicians and other health care professionals are also welcome to attend.
CONTENT
This course provides didactic and hands-on e... |
|
|
Comprehensive Sterile Compounding
December 1-3, 2022
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Completion of the Fundamental Compounding Course is recommended. Physicians and other health care professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy in order to compound sterile prep... |
|
|
Comprehensive Sterile Compounding
August 11-13, 2022
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Completion of the Fundamental Compounding Course is recommended. Physicians and other health care professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy in order to compound sterile prep... |
|
|
Comprehensive Sterile Compounding
May 19-21, 2022
COMPREHENSIVE STERILE COMPOUNDING is an accredited 3-day, 20-hour (2.0 CEUs) practice-based course designed for pharmacists and technicians who are experienced in compounding.
Completion of the Fundamental Compounding Course is recommended. Physicians and other health care professionals are welcome to attend. This course will also provide initial aseptic training for pharmacists and technicians required by their state board of pharmacy in order to compound sterile prepara... |
|
|
Diabetes Update 2022 - LIVE STREAMING
This highly rated Harvard Medical School CME course offers practical strategies to address the medical and systemic challenges to optimal care and updates that ensure you can deliver state-of-the-art care for your patients with diabetes.
PROGRAM HIGHLIGHTS
This program affords you the opportunity to learn from leaders in the field of diabetes who are distinguished for their outstanding teaching, knowledge, and innovations in clinical care.
• Expert guidance to design comprehensive treat... |
|
|
Advanced Pharmaceutical Compounding
October 14-15, 2022
ADVANCED PHARMACEUTICAL COMPOUNDING is an accredited 15 hour (1.5 CEUs) practice-based course designed for pharmacists, technicians, and marketers who want to learn more advanced compounding skills and techniques for the community patient. Both non-sterile and sterile dosage forms will be covered however emphasis will be placed on non-sterile dosage forms.
Physicians and other healthcare professionals are welcome to attend.
This course is a combination of didactic ... |
|
|
PER Postgame™: Protecting Patients with MS from COVID-19—Exploring the Latest in Prevention and Immunosuppressive Treatment Strategies
Target Audience
This educational activity is directed toward community neurologists, neuroimmunologists, MS specialists, specialty nurse practitioners, physician assistants, registered nurses, pharmacists, and other members of the MS care team.
Activity Overview
The COVID-19 pandemic is an unprecedented health care crisis with disproportionate impact on immunocompromised populations. There are unanswered questions and a lack of understanding about the immune response to SARS-CoV-2 vaccine... |
|
|
Ace the Case: Shortness of Breath and Hospital Admittance. What Can I Really Do? (Part 3 of 3-part Series)
Vaccination is the best way to protect against influenza (flu) and possible complications, including pneumonia. Vaccination is especially important for people in groups that are at high risk for serious complications, hospitalization, or death.
Physicians and pharmacists are poised to influence older adults’ decisions to become immunized against potentially preventable diseases. The underutilization and failure of older adults to seek out immunizations may be attributed to unawareness of ... |
|
|
Ace the Case: Preventing the Old Man’s Friend in the Absence of Family Support (Part 2 of 3-part Series)
Vaccination is the best way to protect against influenza (flu) and possible complications, including pneumonia. Vaccination is especially important for people in groups that are at high risk for serious complications, hospitalization, or death.
Physicians and pharmacists are poised to influence older adults’ decisions to become immunized against potentially preventable diseases. The underutilization and failure of older adults to seek out immunizations may be attributed to unawareness of ... |
|
|
Ace the Case: To Vaccinate or Not? Making the Determination for Older Adults (Part 1 of 3-part series)
Vaccination is the best way to protect against influenza (flu) and possible complications, including pneumonia. Vaccination is especially important for people in groups that are at high risk for serious complications, hospitalization, or death.
Physicians and pharmacists are poised to influence older adults’ decisions to become immunized against potentially preventable diseases. The underutilization and failure of older adults to seek out immunizations may be attributed to unawareness of ... |
|
|
Neuromyelitis Optica Spectrum Disorder: Modern Approaches to Diagnosis and Treatment
Target Audience
This activity is designed to meet the educational needs of neurologists, nursing professionals, PAs, pharmacists, and other healthcare professionals involved in the management of patients with neuromyelitis optica spectrum disorder (NMOSD).
Program Overview
The enduring activity is designed to provide evidence-based education on the diagnosis of patients with NMOSD, evidence on novel treatments, and considerations in personalizing therapy.
Learning Objectives
Upon comp... |
|
|
Neuromyelitis Optica Spectrum Disorder: Modern Approaches to Diagnosis and Treatment
Target Audience
This activity is designed to meet the educational needs of neurologists, nursing professionals, PAs, pharmacists, and other healthcare professionals involved in the management of patients with neuromyelitis optica spectrum disorder (NMOSD).
Program Overview
The enduring activity is designed to provide evidence-based education on the diagnosis of patients with NMOSD, evidence on novel treatments, and considerations in personalizing therapy.
Learning Objectives
Upon comp... |
|
|
A Next Generation of Pneumococcal Disease Protection
Target Audience
This activity is intended for infectious disease specialists, primary care physicians, advanced practice providers, pharmacists, nurses and other clinicians who manage adult patients for whom pneumococcal vaccination is recommended.
Program Overview
In this modular video-based activity, multidisciplinary faculty provide their perspectives on the changing epidemiology of pneumococcal disease and the protection afforded by a next generation of conjugate vaccines. Hear expert... |
|
|
A Next Generation of Pneumococcal Disease Protection
In this modular video-based activity, multidisciplinary faculty provide their perspectives on the changing epidemiology of pneumococcal disease and the protection afforded by a next generation of conjugate vaccines. Hear expert insights on considerations for next generation pneumococcal vaccine use, patient access to these newer vaccines, and strategies for engaging patients. Two case studies drive home practical strategies to implement in day-to-day practice.
|
|
|
Practical Tools & Expert Guidance for the Nurse Navigator and Clinical Team: Strategies to Reduce Treatment Disparities in Multiple Myeloma
This immersive practice guide offers a “how to” method for introducing day-to-day strategies in the real world through data, guidelines, and decision-making recommendations. Expert faculty address which approaches may not be working, complexities in managing this patient population, insights on how the latest evidence supports a practical recommendation and review available therapies to optimize treatment selection.
The prevalence of MM is higher in some racial/ethnic minorities and the... |
|
|
Right Treatment, Right Time: A Comprehensive Curriculum on Individualized Treatment Approaches for Multiple Sclerosis
Target Audience
This activity is designed to meet the educational needs of neurology physicians, nurse practitioners, PAs, pharmacists, and other healthcare professionals involved in the care of patients living with MS.
Program Overview
This timely live webinar provides an overview of the efficacy, safety, side effects, and immune system impact of MS disease-modifying therapies. Our distinguished faculty also discuss sequencing considerations, including vaccines, that can impact the c... |
|
|
The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment
Target Audience
This activity is intented for neurologists, nurses, nurse practitioners, PAs, pharmacists, and other members of the healthcare team essential to the diagnosis and management of patients with neuromyelitis optica spectrum disorder.
Program Overview
The educational goal of this activity is to provide clinicians with important information on ensuring an accurate diagnosis of NMOSD and updates on novel treatment options for patients with the disease.
Learning Objectives... |
|
|
ENHANCING DRAVET SYNDROME OUTCOMES: STRATEGIES FOR EARLY DIAGNOSIS AND COMPREHENSIVE MANAGEMENT
TARGET AUDIENCE
The educational design of this activity addresses the needs of neurologists, pediatric neurologists, epileptologists, pediatric epileptologists, pediatricians, primary care providers, general practitioners, nurses, nurse practitioners, physician assistants, and pharmacists involved and/or interested in the management of patients with DS.
STATEMENT OF NEED/PROGRAM OVERVIEW
Despite the importance of early diagnosis, Dravet syndrome (DS) is often misdiagnosed in children an... |
|
|
Data-Driven Decisions in Crohn's Disease: Positioning Patients for Success
While there is a tendency for clinicians to rely on one approach to treating Crohn's disease (CD), making confident data-driven treatment decisions in moderate-to-severe CD is imperative for durable, long-term remission. The traditional approach that has been based on progressive, step-wise treatment intensification with re-evaluation of response according to symptoms does not improve long-term outcomes in CD and increases risk for bowel damage. However, the introduction of treat-to-target (T2... |
|
|
Lipids Health Prime Time™: Episode 2 Expert Opinions on the Role of Nonstatin Therapies: Exploring the Evidence for New and Emerging Nonstatin Options
TARGET AUDIENCE:
This activity has been designed to address the educational needs of cardiologists and primary care physicians, including lipid specialists, internists, family physicians, pharmacists, nurses, nurse practitioners, and PAs.
PROGRAM OVERVIEW:
This fast-paced news broadcast features expert discussions about incorporating new and emerging nonstatin therapies for the lowering of low-density lipoprotein cholesterol (LDL-C) into clinical practice.
LEARNING OBJECTIVES:
At the conc... |
|
|
Developing Targeted, DOAC-Based Therapeutic Strategies for Post-acute, Medically Ill Patients: A Case-Based Discussion
Target Audience
This activity has been designed to address the educational needs of cardiologists, hospitalists, interventional cardiologists, internists, primary care physicians (PCPs), clinical pharmacists, hematologists, and other clinicians who are involved or interested in the medical management of patients with venous thromboembolism (VTE) and/or at risk for VTE.
Program Overview
In the context of a case involving COVID-19, faculty discuss VTE risk assessment using validated ris... |
|
|
Activity 2: Faculty discuss the use of validated VTE and bleeding risk assessment models to inform thromboprophylaxis decisions.
Target Audience
This activity has been designed to address the educational needs of cardiologists, hospitalists, interventional cardiologists, internists, primary care physicians (PCPs), clinical pharmacists, hematologists, and other clinicians who are involved or interested in the medical management of patients with venous thromboembolism (VTE) and/or at risk for VTE.
Program Overview
Faculty discuss the use of validated VTE and bleeding risk assessment models to inform thromboprophy... |
|
|
Activity 1: The Persistent Clinical Problem of VTE in the Post-Acute, Medically Ill Population
Target Audience
This activity has been designed to address the educational needs of cardiologists, hospitalists, interventional cardiologists, internists, primary care physicians (PCPs), clinical pharmacists, hematologists, and other clinicians who are involved or interested in the medical management of patients with venous thromboembolism (VTE) and/or at risk for VTE.
Program Overview
Faculty considers the risk factors for, and burden of, VTE in acutely ill medical patients, during t... |
|
|
Interprofessional Perspectives on Managing Immune-Related Adverse Events
The development of immunotherapies, including ICIs and CAR-T cell agents, is improving survival for some patients with cancer, even in advanced cases. These agents are associated with novel irAEs that are monitored and managed differently than the more familiar standard chemotherapy toxicities. Collaboration among members of the oncology care team is necessary to ensure that all healthcare providers, patients, and caregivers are educated about irAEs and their management. For all members of the... |
|
|
Pediatric Immunizations Should Not Be a Sticking Point
The goal of this CE presentation is to educate licensed pharmacists on pediatric immunization schedules, proper administration, and provide resources/tools to overcome pediatric vaccine hesitancy. By the end of this program, pharmacists will successfully have completed two hours of immunization-related CE in accordance with U.S. Department of Health & Human Services (HHS) requirements. This program is a recorded webinar originally presented in March 2021. |
|
|
Considerations for Antimicrobial Selection in Clostridioides difficile Infection
This educational program is designed for infectious disease pharmacists interested in new therapies and clinical trials in the treatment of CDI. Dr. Paul Feuerstadt and Dr. Kevin Garey discuss community and healthcare-associated infections, recent updates to guidelines, and evidence-based selection of antimicrobial therapy for the treatment of initial infection and prevention of recurrence. What happens if the patient returns with recurrence? Watch to find out as the faculty discuss a patie... |
|
|
Cardiovascular Risk Left Behind: An Interactive Exploration of Triglyceride-Rich Remnant Lipoproteins
TARGET AUDIENCE:
This curriculum and corresponding interventions are designed for Internists, Primary Care Physicians, Family Medicine, Cardiologists, Endocrinologists, Lipid Specialists, Nurse Practitioners, Advanced Practice Nurses, and/or Physicians Assistants, Pharmacists who are involved in the care and treatment of patients with ASCVD.
PROGRAM OVERVIEW:
Join us for this 1-hour interactive online activity with an in-clinic reference guide aimed at providing clinicians with a comprehens... |
|
|
Grand Prix & Mediterranean Cruise: Exploring Medicine, Dentistry & the Mediterranean Healthcare Model
Barcelona to Rome on Crystal Symphony
May 24 – June 2, 2022
Experience the 79th Monaco Grand Prix! Join PES for 9 nights to explore the splendors of the Mediterranean Sea while visiting sun-drenched harbors, discovering archaeological treasures, and experiencing the thrill of the Monaco Grand Prix, while sailing aboard the all-inclusive and award-winning Crystal Symphony! Hosted by Joann & Bill Chaney!
This Seminar is planned for 12 Continuing Education Credit Hours.
CME/CE Pro... |
|
|
The Epidemic Within the Pandemic: Managing Complications in Populations with Obesity
Obesity is increasingly recognized as a multi-causal chronic disease that leads to structural and physiological abnormalities and functional impairments. Despite the growing prevalence and substantial burden of obesity in terms of health-related quality of life (HRQoL), healthcare utilization, and healthcare costs, obesity remains under-diagnosed and under-treated. The recent recognition that obesity is associated with increased risk of morbidity and mortality with coronavirus disease 2019 (CO... |
|
|
Developing an Enhanced Recovery After Surgery (ERAS) Protocol: Best Practices to Reduce Complications in Surgical Patients
Enhanced Recovery after Surgery (ERAS) protocols represent comprehensive, multidisciplinary efforts to expedite postoperative recovery while reducing avoidable complications. Successful implementation of these protocols requires proper coordination between the surgeon, anesthesiologist, nursing personnel, pharmacist, patient, and patient's caregivers in the postoperative period. This has led to a need for interdisciplinary education to ensure that all team members are equipped to optimize pati... |
|
|
Addressing Racial Disparities in Patients with Schizophrenia: Making the Commitment to Do Better
Schizophrenia is a persistent, debilitating disease that depletes individuals and their families of their general well-being, as well as psychosocial and cognitive functioning. Compounding its impact, racial disparities exist in the diagnosis and management of schizophrenia, resulting in racially and ethnically diverse individuals being less likely to have access to mental health services, seek out services, or receive needed care. Racially and ethnically diverse populations, however, are more... |
|
|
How to Use Digital Cognitive Testing Tools to Aid in the Diagnosis of Mild Cognitive Impairment (MCI) and Dementia
Mild cognitive impairment (MCI) is a condition in which individuals demonstrate focal or multifocal impairment with minimal impairment of instrumental activities of daily living (IADL) that does not cross the threshold for dementia diagnosis. It can be the first cognitive expression Alzheimer's disease (AD) or secondary to other disease processes that can cause cognitive deficits. Early diagnosis and intervention can help reduce the burden of AD; however, there are many challenges in diagnosin... |
|
|
Irregular Care: Racial Inequities in the Management of Cardiac Rhythm Disorders
Structural racism and classism leads to many of the social determinants of health (SDoH) that cause disparities in cardiovascular (CVD) care, such as unequal preventative care, heart arrythmia treatment, and research inclusion. Interpersonal racism, including unconscious bias, worsens disproportionate CVD care, and is also a stand-alone factor for this health inequity. Underrepresented minority (URM) patients – particularly Black/African American individuals – are less likely to receive, b... |
|